source Post navigation Rise in weight-management glucose-lowering drug prescriptions in type 1 diabetes patients – News-Medical.Net Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial – Nature.com